Mechanisms of androgen-refractory prostate cancer.

被引：427
|
作者：
Debes, JD [1 ]
Tindall, DJ
机构：
[1] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Biochem, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Mol Biol, Rochester, MN USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 15期
关键词：
D O I：
10.1056/NEJMp048178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1488 / 1490
页数：3
相关论文
共 50 条
  • [1] Androgen receptor signaling in androgen-refractory prostate cancer
    Grossmann, ME
    Huang, HJ
    Tindall, DJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22): : 1687 - 1697
  • [2] Immunotherapy: A new paradigm for androgen-refractory prostate cancer
    Loughlin, Kevin R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (06) : 575 - 575
  • [3] Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells
    Zegarra-Moro, OL
    Schmidt, LJ
    Huang, HJ
    Tindall, DJ
    CANCER RESEARCH, 2002, 62 (04) : 1008 - 1013
  • [4] Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
    Burton, Dominick G. A.
    Giribaldi, Maria G.
    Munoz, Anisleidys
    Halvorsen, Katherine
    Patel, Asmita
    Jorda, Merce
    Perez-Stable, Carlos
    Rai, Priyamvada
    PLOS ONE, 2013, 8 (06):
  • [5] Role of the androgen receptor and PI3K/Akt in the survival of androgen-refractory prostate cancer cells
    Huang, HJ
    Tindall, DJ
    HORMONAL CARCINOGENESIS IV, 2005, : 233 - 244
  • [6] A novel selective heme oxygenase-1 targeted therapy for androgen-refractory prostate cancer
    Alaoui-Jamali, Moulay
    Bismar, Tarek
    Gupta, Ajay
    Szarek, Walter A.
    Schipper, Hyman
    CANCER RESEARCH, 2009, 69
  • [7] HDAC6 inhibition blocks androgen receptor nuclear localization and function in androgen-refractory prostate cancer cells
    Ai, Junkui
    Wang, Yujuan
    Dar, Javid A.
    Nelson, Joel B.
    Wang, Zhou
    JOURNAL OF UROLOGY, 2008, 179 (04): : 190 - 190
  • [8] A novel approach to enhance the therapeutic efficacy of taxol for treating advanced androgen-refractory prostate cancer
    Szarek, Walter A.
    Alaoui-Jamali, Moulay A.
    Gupta, Ajay
    Bismar, Tarek
    Schipper, Hyman M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [9] The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP
    Xie, Bang-Xiang
    Zhang, Hui
    Yu, Lan
    Wang, Jian
    Pang, Bo
    Wu, Rui-Qin
    Qian, Xiao-Long
    Li, Shan-Hu
    Shi, Qing-Guo
    Wang, Le-Le
    Zhou, Jian-Guang
    ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (03) : 405 - 414
  • [10] Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen-refractory state.
    Murillo, H
    Huang, H
    Schmidt, L
    Smith, DI
    Tindall, DJ
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3775S - 3775S
12345